worldnews
domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init
action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/u382397270/domains/mozocare.com/public_html/oncopod/wp-includes/functions.php on line 6114TAFINLAR is a prescription medicine used alone or in combination with trametinib to treat people with a type of skin cancer called melanoma:
Your healthcare provider will perform a test to make sure that TAFINLAR is right for you.
TAFINLAR (alone or in combination with trametinib) is not used to treat people with a type of skin cancer called wild-type BRAF melanoma.
TAFINLAR, in combination with trametinib, may cause fertility problems in females. This could affect your ability to become pregnant. Talk to your healthcare provider if this is a concern for you.
TAFINLAR may cause lower sperm counts in males. This could affect the ability to father a child. Talk to your healthcare provider if this is a concern for you.
Tell your healthcare provider if you have any side effect that bothers you or that does not go away.
Insert text here
Check your skin and tell your healthcare provider right away about any skin changes including:
You should use another effective method of birth control while taking TAFINLAR alone or in combination with trametinib
You and your healthcare provider should decide if you will take TAFINLAR or breastfeed. You should not do both.
Ask your healthcare provider if you do not know.
Before you take TAFINLAR, tell your healthcare provider if you:
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. TAFINLAR and certain other medicines can affect each other, causing side effects. TAFINLAR may affect the way other medicines work, and other medicines may affect how TAFINLAR works. You can ask your pharmacist for a list of medicines that may interact with TAFINLAR.
It is not known if TAFINLAR is safe and effective in children.
Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use TAFINLAR for a condition for which it was not prescribed. Do not give TAFINLAR to other people, even if they have the same symptoms that you have. It may harm them.
Active ingredient: Dabrafenib
Other ingredient: Colloidal silicon dioxide, magnesium stearate, microcrystalline cellulose
Capsule shells: hypromellose, red iron oxide (E172), titanium dioxide (E171).